The Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world for more than a decade. With experts leading the organization and a committed and passionate set of writers and editors, our content is more in-depth than many other sources, which simply copy links to the news from other websites.
In PSM’s round-up this week: FDA and FTC warnings over fake COVID-19 treatments and fraud, as well as fake medicine news in seven U.S. states, Canada and Cambodia.
Seeking a good night’s sleep, 25-year-old Jake Beddoe, a young travel consultant with an adventurous heart and a tremendous sense of humor, took part of what he thought was a Xanax pill on May 27, 2020. The pill was counterfeit, and Jake died of fentanyl poisoning.
In PSM’s round-up this week: news about state drug importation, COVID-19 fraud, fake hand sanitizer stations, and more counterfeit medicine news.
This editorial by Brandon Macsata was published in The International Business Times on November 1, 2020. Macsata has been living with HIV since 2002, and serves as the CEO of the ADAP Advocacy Association, an organization that promotes the AIDS Drug Assistance Program and works to improve access to care.
With the recent report that police in Maui, Hawaii seized 400 counterfeit oxycodone pills made with fentanyl on October 2, 2020, the United States has reached a sobering milestone: public sources have reported about fake pills made with fentanyl in all 50 states.
In PSM’s round-up this week: news about state drug importation, COVID-19 fraud, deadly workout supplements and counterfeit pills made with fentanyl.
A summary briefing of 2020’s major cases, worrying trends and a deep dive into drug supply chain policy issues.
In PSM’s round-up this week: new reports about counterfeit medicine, drug supply chain regulation and phishing scams; FDA warnings about dangerous supplements; a life sentence for fake pill kingpin Aaron Shamo; and more.
In this analysis, which was published in Lexology on October 13, 2020, three global regulatory experts examine barriers to drug importation.
In PSM’s round-up this week: Policy truths about drug importation, prosecutions for fake COVID-19 treatments and financial fraud, and another week in counterfeit pills.